Venture capital firm General Catalyst announced it closed $8 billion in new capital, including $6 billion for its latest fund, Fund XII, and $2 billion in separately managed accounts.
The $8 billion will be used to boost the firm's investments across various sectors, including defense and intelligence, climate and energy, AI, industrials, and healthcare and fintech.
The company will distribute...
Define Ventures, a venture firm whose portfolio consists of well-known early-stage startups in Silicon Valley, received $460 million in Fund III and Opportunities Funds and is looking to expand its investments in digital health.
The firm invested in Folx, which offers virtual healthcare services for the LGBTQ+ community, hybrid women's healthcare provider Tia, digital care management platform...
Dexcom, a medtech device company best known for its continuous glucose monitoring systems, is launching a new venture fund aimed at investing in adjacent businesses.
Called Dexcom Ventures, the new investor will be zeroing in on sensing technology, data analytics, remote patient monitoring and population health. In fact, the new venture is expected to fund companies working in glucose sensing...
AI-enabled diagnostic and treatment platform Paige (formerly Paige.AI) has announced a $100 million Series C round led by Casdin Capital and Johnson & Johnson Innovation. The startup's prior backers and other unnamed funds also took part in the raise.
Paige uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at a lower...
Flare Capital Partners has closed a second health tech investment fund totaling $255 million, a $55 million bump over its original target of $200 million due to interest from new strategic and financial investors, the venture capital firm announced today.
“The logic for the size of the fund was really important,” Michael Greeley, general partner at Flare Capital Partners, told MobiHealthNews. “We...
Qualcomm is already one of the biggest investors in digital health, according to Rock Health.
Qualcomm and Novartis, which announced a partnership just last week for mobile-enabled clinical trials, will also be banding together to start an investment firm, the companies announced ahead of the JP Morgan Healthcare event this week. Qualcomm Ventures and Novartis will leverage up to $100 million...
